关于炎症途径及其交叉对话的见解:关于喘的综合性审查
Sadaf Naz1,2,3, Aimen Wajid2, Marya Nawaz Malik2
1Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, College Station, TX, 77843, USA.
Molecular biology reports
|November 1, 2025
概括
过敏性喘涉及T2和非T2炎症,由不同的细胞和细胞因子驱动. 了解NF-κB,JAK-STAT和MAPK等信号通路的复杂相互作用是开发喘向治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 过敏性喘是一种复杂的呼吸系统疾病,具有异质的炎症特征,包括T2 (eosinophilic) 和非T2 (neutrophilic) 炎症.
- 喘病理生理学与细胞内信号通路的失调密切相关,影响呼吸道炎症和细胞过程.
- 关键的信号通路包括NF-κB,JAK-STAT,MAPK,PI3K和Nrf2,每个都在喘的发展和进展中发挥着不同的作用.
研究的目的:
- 通过检查关键细胞内信号通路的作用和相互作用,阐明导致过敏喘的分子机制.
- 提供有关T2和非T2炎症中涉及的信号通路之间的交叉通话的见解.
- 确定针对过敏性喘的新型个性化治疗干预措施的潜在目标.
主要方法:
- 审查和分析有关喘病理生理学和细胞内信号通路的现有文献.
- 检查NF-κB,JAK-STAT,MAPK,PI3K和Nrf2通路在喘中介炎症反应中的作用.
- 在T2和非T2喘表型的背景下,探索这些信号通路之间的交叉和相互连接.
主要成果:
- 通过增加细胞因子表达,NF-κB信号促进慢性气道炎症.
- MAPK通路有助于炎症反应,调节细胞增殖,生存,分化和亡.
- 在Th2驱动的喘中,JAK-STAT信号传递至关重要,而PI3K则会加剧炎症和氧化应激.
- Nrf2通路作为一种保护机制,防止喘性气道的氧化损伤.
结论:
- 像NF-κB,JAK-STAT,MAPK,PI3K和Nrf2这样的信号通路之间的复杂交互提供了对喘分子基础的更深入的理解.
- 针对这些特定途径及其相互作用,有望开发有效的,个性化的过敏喘治疗方法.
- 对途径交叉的进一步研究可以为管理喘异质性的新型治疗策略铺平道路.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:29Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K